P2X3 receptor antagonists for treatment of pain

Details for Australian Patent Application No. 2008319309 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Vacca, Joseph P.; Nguyen, Diem N.; Potteiger, Craig M.; Paone, Daniel V.; Burgey, Christopher S.

Agent Spruson & Ferguson

Pub. Number AU-B-2008319309

PCT Pub. Number WO2009/058299

Priority 61/132,178 16.06.08 US; 61/001,375 31.10.07 US

Filing date 29 October 2008

Wipo publication date 7 May 2009

Acceptance publication date 6 September 2012

International Classifications

C07C 229/00 Compounds containing amino and carboxyl groups bound to the same carbon skeleton

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058299 Priority application(s): WO2009/058299

6 September 2012 Application Accepted

  Published as AU-B-2008319309

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319310-Biphenyl derivatives as modulators of the histamine-H3 receptor useful for the treatment of disorders related thereto

2008319308-P2X3, receptor antagonists for treatment of pain